Barbiturates, Qualitative, Urine

Overview

The Barbiturates, Qualitative, Urine test is a screening test used to detect the presence of barbiturate drugs in urine. Barbiturates are central nervous system depressants that may be prescribed for seizure disorders, anesthesia, or severe insomnia, but can also be associated with misuse and overdose.

Why This Test is Done

• Detect recent use of barbiturate medications
• Monitor compliance with prescribed treatment
• Screen for drug abuse or overdose
• Support workplace, legal, or rehabilitation drug testing programs
• Assist in the evaluation of unexplained drowsiness, coma, or intoxication

Sample Required

• Urine

Preparation

• No special preparation is required.
• Inform your healthcare provider about any medications, supplements, or herbal products you are taking.

What the Test Detects

This qualitative test reports whether barbiturates are:

• Positive – Barbiturates detected in the urine sample
• Negative – No barbiturates detected above the test cutoff level

Common Barbiturates Detected

• Phenobarbital
• Butalbital
• Pentobarbital
• Secobarbital
• Amobarbital

Clinical Significance

• Helps identify recent barbiturate exposure.
• Useful in emergency settings for suspected poisoning or overdose.
• Supports monitoring of patients receiving barbiturate therapy.
• May be included as part of a comprehensive drug abuse screening panel.

Interpretation

• Negative Result: No detectable barbiturates or levels below the detection threshold.
• Positive Result: Indicates recent barbiturate use or exposure. Confirmatory testing may be recommended for definitive identification.

Turnaround Time

• Typically 1–2 working days

Benefits

• Simple and non-invasive urine test
• Rapid screening for barbiturate exposure
• Supports clinical diagnosis and treatment decisions
• Useful for monitoring and drug screening purposes